MedTrace Logo

Treatment of Bifurcated Coronary Lesions With Cypher™-Stent

NCT00288535 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2007-09-18

No results posted yet for this study

Summary

This study is a prospective, randomized, single-center evaluation of the Cypher™ Sirolimus eluting coronary stent system in the treatment of de novo bifurcated coronary lesions comparing provisional modified T stenting with systematic modified T-stenting.

Conditions

Interventions

PROCEDURE

PCI of bifurcated coronary lesions using sirolimus coated stents in modified T-Stenting -Technique

Sponsors & Collaborators

  • Cordis, Johnson&Johnson company

    collaborator UNKNOWN

  • University Heart Center Freiburg - Bad Krozingen

    lead OTHER

Principal Investigators

  • Miroslaw FERENC, Dr. · Haert Center Bad Krozingen; Germany

  • Franz-Josef Neumann, Prof. Dr. · Heart Center Bad Krozingen, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-03-31
Completion
2007-02-28

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00288535 on ClinicalTrials.gov